You are here

Global Aortic Stent Graft Market 2019-2024 - Opportunities in Growing Popularity of FEVAR, Strategic Mergers & Acquisitions, Emergence of EVAS

DUBLIN, Aug. 15, 2019 /PRNewswire/ -- The "Aortic Stent Graft Market - Global Outlook and Forecast 2019-2024" report has been added to's offering.

The aortic stent graft market is expected to reach over $3.7 billion by 2024, growing at an impressive CAGR of around 6% during 2018-2024.

The commercialization of innovative grafts such as fenestrated aortic stent grafts has further broadened the treatment options for aortic aneurysm, thereby increasing the market for aortic stent grafts. With recent advancements in fenestrated stent graft technology, endovascular approaches are becoming options to treat patients with complex anatomies.

Hence, the rise in the number of aortic aneurysm patient population is expected to contribute to the overall growth of the global aortic stent graft market. Also, the increasing number of government screening programs for the elderly population to detect aortic aneurysm has provided immense growth opportunities for the global aortic stent graft market.

The study considers the present scenario of the market and its market dynamics for the period 2018-2024. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply aspect of the market. The report profiles and examines leading companies and other prominent companies operating in the aortic stent graft market.

Aortic Stent Graft Market: Segmentation

This market research report includes the detailed segmentation of the market by aneurysm, end-users, and geography. The increase in the aging population and the rise of abdominal aortic aneurysm are major factors for the high share of the abdominal aortic aneurysm (AAA) segment in the aortic stent graft market. Further, the market is expected to grow at a healthy rate due to the growing preference for EVAR procedures. In addition, vendors are focusing on bifurcated abdominal aortic stent grafts, which are compatible with EVAR procedures. They are also extensively investing in R&D activities and conducting clinical trials to develop innovative devices.

Hospitals perform aortic aneurysm repair procedures at a large scale for both abdominal and thoracic aortic aneurysms. Hence, the high number of aortic aneurysms, coupled with the wide acceptance of MI procedures over open repair procedures for treating aortic aneurysms, is boosting the market growth of the hospital segment and is likely to continue during the forecast period. The ASC segment is growing at a faster rate than the hospital segment and is expected to grow at a similar rate during the forecast period due to the increasing preference among patients to undergo MI procedures such as TEVAR and EVAR in ASCs than hospitals.

Key Vendor Analysis

The aortic stent graft market is highly consolidated with major players accounting for dominant shares. Key companies have a wide geographical presence, diversified product portfolio, and a strong focus on innovation and research activities. Although major players dominate the market, few emerging companies are gaining traction with their innovative grafts and technologies. Several leading players are focusing on implementing strategies such as product launches, innovative marketing, and promotional activities, strategic acquisitions, increase in R&D investment, and strengthen their distribution networks to enhance their market share and presence in the aortic stent graft market.

Key Vendors

  • Medtronic
  • Cook Medical
  • L. Gore & Associates
  • Endologix
  • MicroPort Scientific
  • Terumo
  • CryoLife

Other Vendors

  • Bentley Innomed
  • BraileBiomdica,
  • Cardinal Health
  • LeMaitre Vascular

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at A Glance

7 Introduction
7.1 Aortic Aneurysm: An Overview
7.1.1 Causes of Aortic Aneurysm
7.1.2 Risk Factors
7.1.3 Symptoms of Aortic Aneurysm
7.1.4 Types of Aortic Aneurysm
7.1.5 Treatment
7.2 Aortic Stent Grafts: An Overview

8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Favorable Patient Demographics
8.1.2 High Demand for MI Aortic Aneurysm Repair Procedures
8.1.3 Increasing Screening Programs for Detection of Aortic Aneurysms
8.1.4 New Product Approvals/Launches
8.2 Market Growth Restraints
8.2.1 Stringent & Varied Regulatory Approval Processes for Aortic Stent Grafts
8.2.2 Risks & Complications Associated with Aortic Stent Grafts
8.3 Market Opportunities & Trends
8.3.1 Growing Popularity of FEVAR
8.3.2 Strategic Mergers & Acquisitions
8.3.3 Emergence of Endovascular Aneurysm Sealing (EVAS)

9 Global Aortic Stent Grafts Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry

10 By Aneurysm Type
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Aortic Stent Grafts for Abdominal Aortic Aneurysm
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.3.3 Aortic Stent Grafts for AAA Segmentation by Geography
10.4 Aortic Stent Grafts for Thoracic Aortic Aneurysm
10.4.1 Market Overview
10.4.2 Market Size & Forecast
10.4.3 Aortic Stent Grafts for TAA Segmentation by Geography

11 By End-User
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Hospitals
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 ASCs
11.4.1 Market Overview
11.4.2 Market Size & Forecast

12 By Geography
12.1 Market Snapshot & Growth Engine
12.2 Market Overview

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets